Patent applications and USPTO patent grants for Pharmacia & Upjohn Company LLC.The latest application filed is for "crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6h)-yl]-n-(2-hydroxyethyl)-4-methylbenzamide".
Patent | Date |
---|---|
Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydroxyethyl)-4-methylbenzamide Grant 8,933,088 - Selbo January 13, 2 | 2015-01-13 |
1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3- -d]pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof Grant 8,518,956 - Tollefson August 27, 2 | 2013-08-27 |
Crystalline Forms Of 3-[5-chloro-4-[(2,4-difluorobenzyl) Oxy]-6-oxopyrimidin-1(6h)-yl]-n-(2-hydroxyethyl)-4-methylbenzamide App 20130158053 - SELBO; Jon G. | 2013-06-20 |
Anti-bacterial Vaccine Compositions App 20120148625 - Lowery; David E. ;   et al. | 2012-06-14 |
Cellular permissivity factor for viruses and uses thereof Grant 8,058,050 - Calvert , et al. November 15, 2 | 2011-11-15 |
Method Of Administering An Injectable Antibiotic To An Animal App 20110098266 - Brown; Scott A. | 2011-04-28 |
Pyridine [3,4-b] pyrazinones Grant 7,902,195 - Hughes , et al. March 8, 2 | 2011-03-08 |
Anti-IgE vaccines Grant 7,897,151 - Morsey , et al. March 1, 2 | 2011-03-01 |
Topical administration of oxazolidinones for transdermal delivery Grant 7,892,574 - Ford , et al. February 22, 2 | 2011-02-22 |
Platform Antibody Compositions App 20110027262 - Das; Tapan ;   et al. | 2011-02-03 |
Vaccines and methods to treat canine influenza Grant 7,879,336 - Shields , et al. February 1, 2 | 2011-02-01 |
Fusion protein of exendin-4 to a transferrin (Tf) polypeptide Grant 7,867,972 - Ballance , et al. January 11, 2 | 2011-01-11 |
Anti-bacterial Vaccine Compositions App 20100322975 - Lowery; David E. ;   et al. | 2010-12-23 |
Cellular Permissivity Factor for Viruses and Uses Thereof App 20100273238 - CALVERT; JAY GREGORY ;   et al. | 2010-10-28 |
Attenuated yiaO mutants of Pasteurellaceae bacteria Grant 7,763,262 - Lowery , et al. July 27, 2 | 2010-07-27 |
Cellular permissivity factor for viruses and uses thereof Grant 7,754,464 - Calvert , et al. July 13, 2 | 2010-07-13 |
Safe mutant viral vaccines Grant 7,754,222 - Welch , et al. July 13, 2 | 2010-07-13 |
Microfluidized Oil-in-water Emulsions and Vaccine Compositions App 20100173854 - Dominowski; Paul J. ;   et al. | 2010-07-08 |
Crystalline Pyrazoles App 20100093820 - Sun; Changquan ;   et al. | 2010-04-15 |
Crystalline pyrazoles Grant 7,652,149 - Sun January 26, 2 | 2010-01-26 |
Tricyclic tetrahydroquinoline antibacterial agents Grant 7,605,157 - Barbachyn , et al. October 20, 2 | 2009-10-20 |
Thiazepine Oxazolidinones as Antibacterial Agents App 20090137553 - Donovan; Charles Francis ;   et al. | 2009-05-28 |
M-CSF Antibody compositions Having Reduced Levels of Endotoxin App 20090117103 - Devalaraja; Madhav ;   et al. | 2009-05-07 |
Substituted hydroxyethylamines Grant 7,498,436 - John , et al. March 3, 2 | 2009-03-03 |
Tricyclic tetrahydroquinoline antibacterial agents Grant 7,208,490 - Barbachyn , et al. April 24, 2 | 2007-04-24 |
Pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators Grant 7,151,109 - Fu December 19, 2 | 2006-12-19 |
NOVEL 3,3-diphenylpropylamines USEFUL IN THERAPY App 20060281812 - Slatter; John Gregory ;   et al. | 2006-12-14 |
Substituted aminoethers for the treatment of alzheimer's disease App 20060194966 - Beck; James P. ;   et al. | 2006-08-31 |
N-Aryl-2-oxazolidinones and their derivatives Grant 7,094,900 - Gadwood , et al. August 22, 2 | 2006-08-22 |
Substituted peptides useful in the treatment of alzheimer's disease App 20060148803 - Beck; James P. | 2006-07-06 |
Anthelmintic and insecticidal compositions Grant 7,071,215 - Lee July 4, 2 | 2006-07-04 |
Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives Grant 7,053,113 - Moon , et al. May 30, 2 | 2006-05-30 |
Inhibitors of HCV NS5B polymerase Grant 7,041,690 - Finzel , et al. May 9, 2 | 2006-05-09 |
3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents Grant 7,034,049 - Pevarello , et al. April 25, 2 | 2006-04-25 |
Photoracamization method App 20060016683 - Chekal; Brian P. ;   et al. | 2006-01-26 |
Enantioselective separation method App 20060020022 - Chekal; Brian P. ;   et al. | 2006-01-26 |
Racemization method App 20060020023 - Ng; John Sauhoi ;   et al. | 2006-01-26 |
Method of synthesizing indolinone compounds App 20060009510 - Havens; Jeffrey L. ;   et al. | 2006-01-12 |
Inhibitors of HCV NS5B polymerase App 20060004063 - Finzel; Barry Craig ;   et al. | 2006-01-05 |
Macrocycles useful in the treatment of alzheimer's disease App 20060003978 - Pulley; Shon R. ;   et al. | 2006-01-05 |
New drug combinations App 20060003992 - Wong; Erik Ho Fong ;   et al. | 2006-01-05 |
Process for the preparation of 9, 11 epoxy steroids App 20050272927 - Wieczorek, Joseph J. ;   et al. | 2005-12-08 |
Method for predicting the sensitivity to chemotherapy Grant 6,969,592 - Fowst , et al. November 29, 2 | 2005-11-29 |
1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position Grant 6,921,823 - Jacobsen , et al. July 26, 2 | 2005-07-26 |
Compositions of a cyclooxygenase-2 selective inhibitor and a neurotrophic factor-modulating agent for the treatment of central nervous system mediated disorders App 20050148589 - Taylor, Duncan P. ;   et al. | 2005-07-07 |
Inhibitors of PACE4 for the treatment of arthritis App 20050090466 - Malfait, Anne-Maria ;   et al. | 2005-04-28 |
Processes and intermediates for preparing benzyl epoxides Grant 6,849,750 - Reeder February 1, 2 | 2005-02-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.